Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prospective Cohort Study on MAFLD-related Cirrhosis Prevention and Treatment Strategies

NCT06135584 is registered in ClinicalTrials.gov with The Affiliated Hospital of Hangzhou Normal University as lead sponsor.

NCT NCT06135584
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06135584 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prospective Cohort Study on MAFLD-related Cirrhosis Prevention and Treatment Strategies
Lead sponsor
The Affiliated Hospital of Hangzhou Normal University
Phase
Not applicable
Overall status
Not yet recruiting
Start date
November 18, 2023
Completion date
December 31, 2026
Enrollment
1,000 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

cirrhosis, metabolic dysfunction-associated fatty liver disease